These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. Kasir R, Zakko S, Zakko P, Adler M, Lee A, Dhingra S, Guttermuth C. Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282 [Abstract] [Full Text] [Related]
5. Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth. Barkin JA, Keihanian T, Barkin JS, Antequera CM, Moshiree B. Rev Gastroenterol Peru; 2019 Mar; 39(2):111-115. PubMed ID: 31333225 [Abstract] [Full Text] [Related]
8. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome. Tuteja AK, Talley NJ, Stoddard GJ, Verne GN. Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492 [Abstract] [Full Text] [Related]
9. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth]. Wei H, Liu ZJ, Wang K, Zheng W, Duan LP. Zhonghua Nei Ke Za Zhi; 2017 Aug 01; 56(8):567-571. PubMed ID: 28789488 [Abstract] [Full Text] [Related]
10. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Eur J Gastroenterol Hepatol; 2014 Jul 01; 26(7):753-60. PubMed ID: 24849768 [Abstract] [Full Text] [Related]
11. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? Reddymasu SC, Sostarich S, McCallum RW. BMC Gastroenterol; 2010 Feb 22; 10():23. PubMed ID: 20175924 [Abstract] [Full Text] [Related]
13. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome. Ning Y, Lou C, Huang Z, Chen D, Huang H, Chen L, Zhang B, Dai N, Zhao J, Zhen X. Hell J Nucl Med; 2016 Feb 22; 19(2):124-9. PubMed ID: 27331205 [Abstract] [Full Text] [Related]
14. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. Zhuang X, Tian Z, Luo M, Xiong L. BMC Gastroenterol; 2020 Jun 12; 20(1):187. PubMed ID: 32532214 [Abstract] [Full Text] [Related]
15. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome. Ding XW, Liu YX, Fang XC, Liu K, Wei YY, Shan MH. Eur Rev Med Pharmacol Sci; 2017 Nov 12; 21(22):5191-5196. PubMed ID: 29228433 [Abstract] [Full Text] [Related]
17. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome. Jung SE, Joo NS, Han KS, Kim KN. J Korean Med Sci; 2017 Jun 12; 32(6):948-953. PubMed ID: 28480652 [Abstract] [Full Text] [Related]
18. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. Collins BS, Lin HC. J Pediatr Gastroenterol Nutr; 2011 Apr 12; 52(4):382-6. PubMed ID: 21240023 [Abstract] [Full Text] [Related]
19. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Digestion; 2012 Apr 12; 85(3):243-7. PubMed ID: 22472730 [Abstract] [Full Text] [Related]